Stevanato Group S.p.A (STVN) Shares Outstanding (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Shares Outstanding (Entity) of $273.0 million for Q1 2026, little changed year-over-year from $272.9 million in Q1 2025, and down 9.85% quarter-over-quarter from $302.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Shares Outstanding (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Shares Outstanding (Entity) for 7 consecutive years, with $273.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.04% year-over-year to $273.0 million; the TTM figure through Mar 2026 stood at $273.0 million (changed 0.04% YoY), while the FY2025 annual figure was $302.8 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) slipped to $273.0 million in Q1 2026 per STVN's latest filing, from $302.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $302.8 million in Q4 2024 and bottomed at $264.7 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $275.8 million across 5 years, with a median of $272.9 million in 2024.
- On a YoY basis, Shares Outstanding (Entity) climbed as much as 10.02% in 2022 and fell as far as 0.0% in 2022.
- Stevanato Group S.p.A's Shares Outstanding (Entity) stood at $295.5 million in 2022, then changed by 0.0% to $295.5 million in 2023, then gained by 2.47% to $302.8 million in 2024, then changed by 0.0% to $302.8 million in 2025, then declined by 9.85% to $273.0 million in 2026.
- Business Quant data shows STVN's Shares Outstanding (Entity) at $273.0 million in Q1 2026, $302.8 million in Q4 2025, and $273.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 273.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 273.03 Mn |
| Mar 31, 2026 | 273.00 Mn |
| Dec 31, 2025 | 272.95 Mn |
| Sep 30, 2025 | 273.00 Mn |
| Jun 30, 2025 | 272.90 Mn |
| Mar 31, 2025 | 272.90 Mn |
| Dec 31, 2024 | 271.14 Mn |
| Sep 30, 2024 | 272.90 Mn |
| Jun 30, 2024 | 272.80 Mn |
| Mar 31, 2024 | 265.90 Mn |
| Dec 31, 2023 | 264.95 Mn |
| Sep 30, 2023 | 264.90 Mn |
| Jun 30, 2023 | 264.70 Mn |
| Mar 31, 2023 | 264.70 Mn |
| Dec 31, 2022 | 264.70 Mn |
| Sep 30, 2022 | 264.70 Mn |
| Jun 30, 2022 | 264.70 Mn |
| Mar 31, 2022 | 264.70 Mn |
| Dec 31, 2021 | 252.67 Mn |
| Sep 30, 2021 | 264.50 Mn |